Impact of Brokerage Rating on Humana Inc.(HUM)

Many Humana Inc.(HUM) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Humana Inc was Resumed by BofA/Merrill to Buy on Jan 27, 2017. Humana Inc was Downgraded by Stifel on Jan 24, 2017 to Hold, Lowers Price Target to $ 210 from a previous price target of $214 .Humana Inc was Initiated by Piper Jaffray to Overweight on Jan 4, 2017. Humana Inc was Downgraded by Cantor Fitzgerald to Hold on Dec 7, 2016.

Company has reported several Insider transactions to the SEC, on Feb 29, 2016, Brian P. Leclaire (SVP & Chief Information Off.) sold 183 shares at 176.11 per share price.On Mar 12, 2015, James E Murray (EVP & COO) sold 35,220 shares at 160.93 per share price.On Feb 27, 2015, David A Jr/ky Jones (director) sold 6,100 shares at 165.39 per share price.

Humana Inc Last issued its quarterly earnings results on Feb 8, 2017. The company reported $2.09 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $2.08. The company had revenue of $13461.00 million for the quarter, compared to analysts expectations of $13540.09 million. The companys revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS.

Humana Inc. (NYSE:HUM) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.85 by 13 Brokerage Firm. 7 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 5 Brokerage Firms have advised hold.

Humana Inc. (NYSE:HUM) stock has received a short term price target of $ 219.55 from 11 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $24.98. The higher estimate of target price is $250 , while the lower price target estimate is $170

Humana Inc. (NYSE:HUM) witnessed a decline in the market cap on Tuesday as its shares dropped 0.35% or 0.73 points. After the session commenced at $207.49, the stock reached the higher end at $207.6152 while it hit a low of $204.86. With the volume soaring to 2,230,191 shares, the last trade was called at $205.97. The company has a 52-week high of $217.8. The company has a market cap of $30,752 million and there are 149,305,200 shares in outstanding. The 52-week low of the share price is $150.

Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The companys products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers compensation, and administrative services to those who self-insure their employee health plans.

Humana

For any feedback and suggestions contact author at Jim.Swaby@thefoundersdaily.com

Add Comment